• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者心率增加时 PR 间期的变化。

Behavior of the PR interval with increasing heart rate in patients with COVID-19.

机构信息

Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.

Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.

出版信息

Heart Rhythm. 2020 Sep;17(9):1434-1438. doi: 10.1016/j.hrthm.2020.06.009. Epub 2020 Jun 11.

DOI:10.1016/j.hrthm.2020.06.009
PMID:32535142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7289083/
Abstract

BACKGROUND

Myriad manifestations of cardiovascular involvement have been described in patients with coronavirus disease 2019 (COVID-19), but there have been no reports of COVID-19 affecting the cardiac conduction system. The PR interval on the electrocardiogram (ECG) normally shortens with increasing heart rate (HR). The case of a patient with COVID-19 manifesting Mobitz type 1 atrioventricular (AV) block that normalized as the patient's condition improved prompted us to investigate PR interval behavior in patients with COVID-19.

OBJECTIVE

The purpose of this study was to characterize PR interval behavior in hospitalized patients with COVID-19 and to correlate that behavior with clinical outcomes.

METHODS

This study was a cross-sectional cohort analysis of confirmed COVID-19 cases (March 26, 2020, to April 25, 2020). We reviewed pre-COVID-19 and COVID-19 ECGs to characterize AV conduction by calculating the PR interval to HR (PR:HR) slope. Clinical endpoints were death or need for endotracheal intubation.

RESULTS

ECGs from 75 patients (246 pre-COVID-19 ECGs and 246 COVID-19 ECGs) were analyzed for PR:HR slope. Of these patients, 38 (50.7%) showed the expected PR interval shortening with increasing HR (negative PR:HR slope), whereas 37 (49.3%) showed either no change (8 with PR:HR slope = 0) or paradoxical PR interval prolongation (29 with positive PR:HR slope) with increasing HR. Patients without PR interval shortening were more likely to die (11/37 [29.7%] vs 3/38 [7.9%]; P = .019) or require endotracheal intubation (16/37 [43.2%] vs 8/38 [21.1%]; P = .05) compared to patients with PR interval shortening.

CONCLUSION

Half of patients with COVID-19 showed abnormal PR interval behavior (paradoxical prolongation or lack of shortening) with increasing HR. This finding was associated with increased risk of death and need for endotracheal intubation.

摘要

背景

在新冠肺炎(COVID-19)患者中,已经描述了心血管受累的多种表现,但尚未有报道称 COVID-19 会影响心脏传导系统。心电图(ECG)的 PR 间期通常随着心率(HR)的增加而缩短。我们报道了一例 COVID-19 患者表现出莫氏Ⅰ型房室(AV)阻滞,随着病情的改善而恢复正常,这促使我们研究 COVID-19 患者的 PR 间期行为。

目的

本研究旨在描述住院 COVID-19 患者的 PR 间期行为,并将其与临床结局相关联。

方法

这是一项横断面队列分析研究,纳入了 2020 年 3 月 26 日至 4 月 25 日期间确诊的 COVID-19 病例。我们回顾了 COVID-19 之前和 COVID-19 期间的心电图,通过计算 PR 间期与 HR(PR:HR)斜率来描述 AV 传导。临床终点为死亡或需要气管插管。

结果

对 75 例患者(246 份 COVID-19 之前的心电图和 246 份 COVID-19 期间的心电图)的 PR:HR 斜率进行了分析。其中,38 例(50.7%)表现出与预期相符的 PR 间期随 HR 增加而缩短(PR:HR 斜率为负),而 37 例(49.3%)表现为 PR 间期无变化(8 例 PR:HR 斜率=0)或随 HR 增加而出现矛盾的 PR 间期延长(29 例 PR:HR 斜率为正)。没有 PR 间期缩短的患者更有可能死亡(37/37 [29.7%] vs 38/38 [7.9%];P=0.019)或需要气管插管(37/37 [43.2%] vs 38/38 [21.1%];P=0.05)。

结论

一半的 COVID-19 患者表现出异常的 PR 间期行为(矛盾的延长或无缩短),随 HR 增加而出现。这一发现与死亡和需要气管插管的风险增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e1c/7289083/984e9b12b4a9/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e1c/7289083/0bf57ec3bab9/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e1c/7289083/6a2ce3c04b44/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e1c/7289083/984e9b12b4a9/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e1c/7289083/0bf57ec3bab9/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e1c/7289083/6a2ce3c04b44/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e1c/7289083/984e9b12b4a9/gr2_lrg.jpg

相似文献

1
Behavior of the PR interval with increasing heart rate in patients with COVID-19.COVID-19 患者心率增加时 PR 间期的变化。
Heart Rhythm. 2020 Sep;17(9):1434-1438. doi: 10.1016/j.hrthm.2020.06.009. Epub 2020 Jun 11.
2
Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019.强化 2019 冠状病毒疾病患者的心电图监测。
Heart Rhythm. 2020 Sep;17(9):1417-1422. doi: 10.1016/j.hrthm.2020.04.047. Epub 2020 May 6.
3
Cardiac Arrhythmias in COVID-19 Infection.新型冠状病毒肺炎感染中的心律失常
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008719. doi: 10.1161/CIRCEP.120.008719. Epub 2020 May 20.
4
Electrocardiographic Changes and Arrhythmias in Hospitalized Patients With COVID-19.COVID-19住院患者的心电图变化和心律失常
Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e009023. doi: 10.1161/CIRCEP.120.009023. Epub 2020 Sep 15.
5
Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization.在以非裔美国人为主的新冠病毒疾病样本中,神经系统并发症预示着住院期间的预后更差。
Clin Neurol Neurosurg. 2020 Oct;197:106173. doi: 10.1016/j.clineuro.2020.106173. Epub 2020 Aug 25.
6
Arrhythmic Complications of Patients Hospitalized With COVID-19: Incidence, Risk Factors, and Outcomes.新冠肺炎住院患者的心律失常并发症:发病率、危险因素及预后
Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e009121. doi: 10.1161/CIRCEP.120.009121. Epub 2020 Sep 15.
7
Electrocardiographic/QT interval monitoring with a portable device in hospitalized patients with COVID-19: a protocol proposal.使用便携式设备对新冠肺炎住院患者进行心电图/QT间期监测:一项方案建议
Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):771-773. doi: 10.1016/j.rec.2020.05.027. Epub 2020 Jun 25.
8
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.氯喹、羟氯喹和阿奇霉素对 SARS-CoV-2 感染患者校正 QT 间期的影响。
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662. doi: 10.1161/CIRCEP.120.008662. Epub 2020 Apr 29.
9
The prognostic significance of electrocardiography findings in patients with coronavirus disease 2019: A retrospective study.心电图检查在 2019 冠状病毒病患者中的预后意义:一项回顾性研究。
Clin Cardiol. 2021 Jul;44(7):963-970. doi: 10.1002/clc.23628. Epub 2021 May 11.
10
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval.症状性儿科 SARS-CoV-2 感染 PCR 阳性患者心律失常和心电图异常的发生率,包括校正 QT 间期的药物诱导变化。
Heart Rhythm. 2020 Nov;17(11):1960-1966. doi: 10.1016/j.hrthm.2020.06.033. Epub 2020 Jul 1.

引用本文的文献

1
Complete Heart Block: A Case Report and Review of a Rare Manifestation of COVID-19.完全性心脏传导阻滞:1例COVID-19罕见表现的病例报告及文献复习
ARYA Atheroscler. 2022 Jun;18(6):2357. doi: 10.48305/arya.2022.16329.2357. Epub 2022 Dec 1.
2
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients.白细胞介素-6水平升高与重症COVID-19患者的房室传导延迟有关。
J Arrhythm. 2024 Jul 31;40(5):1137-1148. doi: 10.1002/joa3.13114. eCollection 2024 Oct.
3
Clinical Characteristics and Comparative Proteomics Analysis of COVID-19-Related Atrioventricular Block.

本文引用的文献

1
Cardiac Arrhythmias in COVID-19 Infection.新型冠状病毒肺炎感染中的心律失常
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008719. doi: 10.1161/CIRCEP.120.008719. Epub 2020 May 20.
2
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.新冠病毒肺炎患者的狼疮抗凝物与异常凝血检测
N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.
3
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.心血管疾病、药物治疗与新冠病毒感染相关死亡率
新型冠状病毒肺炎相关房室传导阻滞的临床特征及比较蛋白质组学分析
Rev Cardiovasc Med. 2024 May 28;25(6):195. doi: 10.31083/j.rcm2506195. eCollection 2024 Jun.
4
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.新型冠状病毒病肺外并发症的发病机制及其治疗意义。
Signal Transduct Target Ther. 2022 Feb 23;7(1):57. doi: 10.1038/s41392-022-00907-1.
5
ECG-BiCoNet: An ECG-based pipeline for COVID-19 diagnosis using Bi-Layers of deep features integration.ECG-BiCoNet:一种基于心电图的 COVID-19 诊断管道,使用两层深度特征融合。
Comput Biol Med. 2022 Mar;142:105210. doi: 10.1016/j.compbiomed.2022.105210. Epub 2022 Jan 5.
6
Incidence of Atrioventricular Blocks and its Association with In-Hospital Mortality and Morbidity in Patients with Coronavirus Disease 2019.2019 年冠状病毒病患者房室传导阻滞的发生率及其与住院病死率和发病率的关系。
J Cardiol. 2022 Apr;79(4):482-488. doi: 10.1016/j.jjcc.2021.10.025. Epub 2021 Nov 1.
7
Phenotypic heterogeneity of COVID-19 pneumonia: clinical and pathophysiological relevance of the vascular phenotype.COVID-19 肺炎的表型异质性:血管表型的临床和病理生理学相关性。
ESC Heart Fail. 2022 Feb;9(1):263-269. doi: 10.1002/ehf2.13602. Epub 2021 Nov 10.
8
Unravelling Atrioventricular Block Risk in Inflammatory Diseases: Systemic Inflammation Acutely Delays Atrioventricular Conduction via a Cytokine-Mediated Inhibition of Connexin43 Expression.揭开炎症性疾病中心房-心室传导阻滞风险的面纱:全身炎症通过细胞因子介导的Connexin43 表达抑制使房室传导急性延迟。
J Am Heart Assoc. 2021 Nov 2;10(21):e022095. doi: 10.1161/JAHA.121.022095. Epub 2021 Oct 29.
9
Deep Learning Methods for Remote Heart Rate Measurement: A Review and Future Research Agenda.深度学习方法在远程心率测量中的应用:综述与未来研究议程。
Sensors (Basel). 2021 Sep 20;21(18):6296. doi: 10.3390/s21186296.
10
Complete heart block in patients infected with SARS-CoV-2: A case series from a developing country.感染新型冠状病毒肺炎患者的完全性心脏传导阻滞:来自一个发展中国家的病例系列
Ann Med Surg (Lond). 2021 Sep;69:102828. doi: 10.1016/j.amsu.2021.102828. Epub 2021 Sep 6.
N Engl J Med. 2020 Jun 18;382(25):e102. doi: 10.1056/NEJMoa2007621. Epub 2020 May 1.
4
Clinical determinants of the PR interval duration in Swiss middle-aged adults: The CoLaus/PsyCoLaus study.瑞士中年成年人 PR 间期持续时间的临床决定因素:CoLaus/PsyCoLaus 研究。
Clin Cardiol. 2020 Jun;43(6):614-621. doi: 10.1002/clc.23356. Epub 2020 Apr 24.
5
ST-Segment Elevation in Patients with Covid-19 - A Case Series.新型冠状病毒肺炎患者的ST段抬高——病例系列
N Engl J Med. 2020 Jun 18;382(25):2478-2480. doi: 10.1056/NEJMc2009020. Epub 2020 Apr 17.
6
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.